Oncology PracticeHead and neck cancer cost analysis yields simple bundled payment modelApril 29, 2019Head & Neck/Thyroid CancersPractice Management
Oncology PracticeBWH classification system better predicts outcomes in HNCSCCApril 25, 2019Head & Neck/Thyroid Cancers
Oncology PracticeSurvival after squamous recurrence may be unaffected by immune statusApril 23, 2019Head & Neck/Thyroid Cancers
Oncology PracticeMouthwash shows some efficacy for oral mucositis painApril 19, 2019Head & Neck/Thyroid CancersPatient & Survivor Care
Oncology PracticeATA risk stratification for DTC performs well in real-world cohortApril 13, 2019Head & Neck/Thyroid Cancers
Oncology PracticeAntibiotics gut checkpoint inhibitor efficacyMarch 12, 2019Immuno-oncologyHead & Neck/Thyroid CancersLung CancerMelanoma
Oncology PracticeCharacteristics of mucinous adenocarcinoma highlightedFebruary 9, 2019Head & Neck/Thyroid Cancers
Oncology PracticeEnoblituzumab plus pembrolizumab shows promise for select solid tumorsFebruary 7, 2019Lung CancerImmuno-oncologyHead & Neck/Thyroid Cancers
Oncology PracticeClinical trial: The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell CarcinomaDecember 18, 2018Head & Neck/Thyroid Cancers
The Journal of Community and Supportive OncologyImmunotherapy may hold the key to defeating virally associated cancersNovember 25, 2018Head & Neck/Thyroid CancersGenitourinary CancerGynecologic CancerGastroenterologyImmunotherapyLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Oncology PracticeMonalizumab-cetuximab combo shows promise in advanced head and neck SCCNovember 19, 2018Immuno-oncologyHead & Neck/Thyroid Cancers
Oncology PracticeAdding pembrolizumab to cisplatin-based CRT shows promise in HPV+ head and neck cancersNovember 12, 2018Head & Neck/Thyroid CancersImmuno-oncology
Oncology PracticePembrolizumab extends survival of head and neck cancerNovember 1, 2018Head & Neck/Thyroid CancersImmuno-oncology
Oncology PracticeWorse OS, control of low-risk oropharyngeal cancer with cetuximabOctober 30, 2018Head & Neck/Thyroid Cancers
Oncology PracticeESMO 2018: First look at immunotherapy as first-line treatment for HNSCCOctober 12, 2018Head & Neck/Thyroid Cancers
